Kaiser Permanente
Division of Research Spotlight

The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.

Work by the Division of Research Makes Top JAMA Lists for 2018

January 14, 2019
Breastfeeding, Cancer, Cardiovascular, Feature, Maternal/infant health, Vaccine research, Vaccines, Women’s health
0 Comments

The JAMA Network, the publication home for numerous top-tier journals from the American Medical Association, released a list of the “Most Talked About Articles” in each of their various publications for 2018. DOR research appears on four lists.

Flu Vaccine Prevents Flu-Related Hospitalizations in Pregnant Women

Kaiser Permanente collaborated with CDC researchers to study the effectiveness of flu vaccinations in preventing influenza-associated hospitalizations during pregnancy.

Children With Autism and Their Younger Siblings Less Likely to Be Fully Vaccinated

March 26, 2018
Adolescent Health, Autism, Vaccine research, Vaccines
0 Comments

Children with autism and their younger siblings are significantly less likely to be fully vaccinated than the general population, according to new research published in JAMA Pediatrics.

Eight Weeks or Twelve? Kaiser Permanente Study Shows Shorter Hepatitis C Regimen Effective in Black Patients

March 15, 2018
Disparities, Infectious disease, Uncategorized, Vaccine research, Vaccines
0 Comments

A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.

Why Parents Should Continue to Vaccinate Their Kids

August 10, 2017
Children’s health, Prevention, Vaccine research, Vaccines
0 Comments

As a research scientist for the Kaiser Permanente Northern California Division of Research and director of KP’s Vaccine Study Center, it’s Nicola Klein's job to study the safety and effectiveness of both new and older vaccines.

Maternal Pertussis Vaccination Reduces Risk for Newborns by More Than 90 Percent

April 2, 2017
Maternal/infant health, Press Release, Uncategorized, Vaccine research, Vaccines
0 Comments

Among infants of women who received the Tdap pertussis booster vaccine during pregnancy, the risk of contracting pertussis was reduced by an estimated 91 percent during the first two months of life — the critical period before they can receive…

Vaccine Study Center Research Yields Valuable Knowledge on Vaccines for Children and Adolescents

November 13, 2012
Adolescent Health, Children’s health, Health maintenance, Prevention, Vaccines
0 Comments

The Kaiser Permanente Vaccine Study Center (VSC), which conducts research to advance scientific understanding of vaccines at all levels of development, published widely-covered studies this fall on both the deficiencies and general safety of two vaccines for children and adolescents.…

Kaiser PermanenteDivision of Research Spotlight

Kaiser Permanente
Division of Research Spotlight